Obtaining Second Opinion Delays Treatment for Breast Cancer, but Not Appreciably
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, May 6, 2025 -- For patients with newly diagnosed breast cancer, obtaining a second opinion is associated with increased overall time from diagnosis to treatment; however, time to treatment still falls well within the guidelines, according to a study presented at the annual meeting of the American Society of Breast Surgeons, held from April 30 to May 4 in Las Vegas.
Pooja Varman, M.D., from the Cleveland Clinic Foundation, and colleagues compared time to first treatment between patients with newly diagnosed breast cancer who seek a second opinion (external) and those diagnosed within the same institution (internal) in a retrospective cohort study. Participants with new stage 0 to III breast cancer diagnosed externally and internally (113 in each group) and treated at a single cancer center between January and July 2024 were included.
The researchers found that the median time from biopsy to first treatment was 35 days, with a significant difference between external and internal patients (41.5 versus 31 days). The median time from first surgical oncology clinic appointment at the study institution to first treatment (TCT) was 21 days, with no significant difference between external and internal patients (20 and 21 days, respectively). Compared with internal patients, external patients required additional imaging and biopsies significantly more frequently (90.3 versus 68.1 percent). There was a correlation between the need for additional workup and increased median TCT. A correlation was also seen for the need for a plastic surgeon consultation with increased median TCT.
"Cleveland Clinic internal patients had an even shorter time to treatment, but external patients' average time to treatment was still well within guidelines," Varman said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-07 12:00
Read more

- Too Much Cinnamon May Interfere With Some Medications, Study Shows
- Uplizna (inebilizumab-cdon) is Now the First and Only FDA-Approved Treatment for IgG4-Related Disease
- Follow-Up Test For High Blood Pressure Condition Not Worthwhile, Researchers Say
- Showerhead Water Limits Rescinded as Trump Targets Household Appliances
- Adult Acne Increases Risk Of Eating Disorders
- Medicare Advantage Plans Squeezing Billions More From U.S. Government
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions